Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 25 results for "gilead sciences"

Gilead to buy Kite Pharma for about $12 billion

REUTERS - Gilead Sciences Inc has agreed to buy immunotherapy developer Kite Pharma Inc in an all-cash deal valued at $11.9 billion, the companies said on Monday. Business Standard, 1 month ago
Gilead to buy Kite Pharma in $11 billion deal - WSJ Business Standard, 1 month ago

1 images for "gilead sciences"

Money Control, 4 months ago

U.S. FDA approves Gilead cancer gene therapy; price set at $373,000

U.S. regulators approved on Wednesday a new therapy for a type of lymphoma, which was developed by Gilead Science Inc’s Kite Pharma, marking the second approval for this potentially revolutionary approach to fighting cancer. The Food and Drug ...
 Reuters21 hours ago Gilead cancer immunotherapy wins U.S. approval with $373,000 price  Reuters22 hours ago
Sify

US STOCKS-Wall St edges up as health, home improvement chains climb

* Dollar falls to 16-month low before recovering slightly * Kite Pharma soars after $11.9 bln deal with Gilead * Home Depot, Lowe's up on hopes of post-Harvey gains * Indexes up: Dow 0.08 pct, S&P 0.18 pct, Nasdaq 0.21 pct(Updates to open) By Sruthi Shankar ...
 Sify1 month ago US STOCKS-Wall St set for higher open; Harvey puts energy in focus  Sify1 month ago US STOCKS-Wall St gains after strong data but N.Korea worries linger  Sify1 month ago Wall Street gains after strong data but N.Korea worries linger  Sify1 month ago
Sify

US STOCKS-Wall St closes little changed as Harvey pummels Texas

* U.S. crude falls but gasoline prices rise * Home Depot up on hopes of post-Harvey gains * Travelers fall weighs the most on Dow * Kite Pharma soars after $11.9 bln deal with Gilead * Dow off 0.17 pct, S&P up 0.12 pct, Nasdaq up 0.17 pct(Updates to market ...
 Sify1 month ago US STOCKS-S&P, Dow flat as investors weigh impact of Harvey  Sify1 month ago US STOCKS-S&P, Dow edge lower as Harvey batters oil market  Sify1 month ago Wall Street closes little changed as Harvey pummels Texas  Sify1 month ago

US STOCKS-Futures flat as Hurricane Harvey weighs on oil, dollar

* Futures up: Dow 2 pts, S&P 1.75 pts, Nasdaq 2 pts By Sruthi Shankar Aug 28 (Reuters) - U.S. stock index futures were littlechanged on Monday as Tropical Storm Harvey barreled into theTexas coast, the heart of the U.S. energy sector, raisingconcerns about ...
 Sify1 month ago US STOCKS-Futures edge up ahead of Fed decision; earnings in focus  Sify2 months ago

Aurobindo Pharma gets USFDA nod for anti-HIV drug

Aurobindo Pharma has received tentative approval from the USFDA for dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets, used for the treatment of HIV, in the US market. In a BSE filing, Aurobindo Pharma said it has received "tentative approval ...
 Business Standard1 month ago

Mylan Pharma launches chronic hepatitis C drug in India

BS ReporterHyderabad, 27 July: Mylan Pharmaceuticals Private Limited, a subsidiary of Mylan N V, today announced the launch of Velpatasvir 100 mg/Sofosbuvir 400 mg tablets under the brand name MyHep All in India. MyHep All is a fixed-dose combination tablet ...
 Business Standard2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less